0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

The Antiproteinuric Effect of Antihypertensive Agents in Diabetic Nephropathy

Ronald T. Gansevoort, MD; Alfred J. Apperloo, MD; Jan E. Heeg, MD; Paul E. de Jong, MD; Dick de Zeeuw, MD
Arch Intern Med. 1992;152(10):2137-2138. doi:10.1001/archinte.1992.00400220139024.
Text Size: A A A
Published online

To the Editor.—  In a recent article, Valentino and associates1 present evidence that angiotensin-converting enzyme (ACE) inhibitors and certain calcium channel antagonists (CCAs) confer beneficial effects on renal function in diabetic nephropathy above and beyond those attributable solely to blood pressure lowering per se. In the same issue, Epstein,2 in his editorial article, considers some of the issues raised by Valentino et al. Both articles1,2 conclude, given the presently available data, that both ACE inhibitors and CCAs can effectively reduce urinary protein excretion and may preserve renal function. However, the effects of CCAs appear to vary considerably. Several factors are proposed by the authors that may explain the ultimate renal response to a CCA, including the type of CCA1 and the level of preexisting renal function.2 Although we tend to agree with the line of reasoning used by the authors of both articles, we would

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Web of Science® Times Cited: 15

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();